Clinical Trial: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant Anfibatide Injection in Healthy Volunteers

U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07887490) titled 'Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant Anfibatide Injection in Healthy Volunteers' on Oct. 10.

Brief Summary: This is a Phase I, dose-escalation study to evaluate the safety, tolerability, and pharmacokinetics of Recombinant Anfibatide Injection in healthy adult volunteers.

Approximately 36 healthy participants will receive a single intravenous dose of either study drug or matching placebo across sequential dose cohorts. Safety, tolerability, and pharmacokinetic parameters will be assessed following administration.

Study Start Date: Nov. 30

Study Type: INTERVENTIONAL

Condition: Healthy V...